EAU 2021 Prostate Cancer - Results from #20

Viewing 21-40 of 71 articles

EAU 2021: 68Ga-PSMA PET/CT for Recurrent Prostate Cancer After Radical Prostatectomy: What’s Next? Analysis from a Single, High Volume Tertiary Referral Center

EAU 2021: Radiotherapy After Radical Prostatectomy in the PSMA-PET Era

EAU 2021: PET/CT Allows for a Reliable Assessment of the Real Nodal Burden in Clinically Node-Positive Prostate Cancer Patients Candidate for Radical Prostatectomy: Results from a Multi-Institutional Series

EAU 2021: Impact of Late Dosing on Testosterone Suppression with Two Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere – an Analysis of US Clinical Data

EAU 2021: Hormone Treatment–related Adverse Events (HTR AEs) with Darolutamide (DARO) in Patients (Pts) with Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC) from the Phase 3 ARAMIS Study

EAU 2021: Clinical Benefit and Safety Profile of Darolutamide in Patients Who Crossed over to Darolutamide from Placebo During the Open-Label Period of the Phase 3 ARAMIS Study

EAU 2021: Ultra-Fast Biparametric MRI for Prostate Cancer Detection

EAU 2021: Treatment Options for Recurrent mHSPC - Systemic Treatments: When and How?

EAU 2021: Treatment Options That Offer a Survival Benefit in mCRPC Discussion: The TheraP and VISION Trials

EAU 2021: Treatment Options for Recurrent mHSPCa: The Role of Imaging-Guided Treatments: Radiotherapy

EAU 2021: De Novo Versus Recurrent Metastatic mHSPC: What Is the Role of Modern Imaging?

EAU 2021: Treatment Options for Recurrent mHSPC: The Role of Imaging-Guided Treatments: Surgery

EAU 2021: Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer: A Pooled Analysis of Prospective Trials

EAU 2021: Fatigue, Quality-of-Life and Metabolic Changes in Men Treated With Enzalutamide Versus Abiraterone Plus Prednisone (HEAT): A Randomized Trial

EAU 2021: cN+ and Systemic Treatment: Guidelines Point of View More Than ADT is Needed as Systemic TTT: No!

EAU 2021: cN+ and Local Treatment: Guidelines Point of View

EAU 2021: Tumor Molecular Testing: For Whom and When Is It Clinically Useful?

EAU 2021: Monitoring and When To Change Treatment In mHSPC

EAU 2021: PSMA In Diagnostics and Treatment

EAU 2021: An Overview of Systemic Treatment Options for mCRPC

1
2
3
4